Human cell‐derived microparticles promote thrombus formation in vivo in a tissue factor‐dependent manner

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Thrombosis and Haemostasis

• Publication date

  2003-12-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1046/j.1538-7836.2003.00456.xPMID 14738565
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets

  2003cited by this paper
• Pro‐ and non‐coagulant forms of non‐cell‐bound tissue factor in vivo

  2003cited by this paper
• Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque.

  2002cited by this paper
• The presence and release of tissue factor from human platelets

  2002cited by this paper
• Transfer of Tissue Factor from Platelets to Monocytes: Role of Platelet-Derived Microvesicles and CD62P

  2002influential reference
• Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions.

  2002cited by this paper
• Cell-derived Microparticles Circulate in Healthy Humans and Support Low Grade Thrombin Generation

  2001influential reference
• Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation.

  2001cited by this paper
• Aprotinin administration in the pericardial cavity does not prevent platelet activation.

  2001cited by this paper
• Microparticles from Patients with Multiple Organ Dysfunction Syndrome and Sepsis Support Coagulation through Multiple Mechanisms

  2001cited by this paper
• Aprotinin administration in the pericardial cavity does not prevent platelet activation.

  2000cited by this paper
• Tissue Factor Is Rapidly Elevated in Plasma Collected from the Pericardial Cavity during Cardiopulmonary Bypass

  2000cited by this paper
• Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes.

  2000cited by this paper
• Cellular origin and procoagulant properties of microparticles in meningococcal sepsis.

  2000cited by this paper
• Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor.

  2000cited by this paper
• Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity.

  1999cited by this paper
• Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina.

  1999cited by this paper
• Blood-borne tissue factor: another view of thrombosis.

  1999cited by this paper
• In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.

  1999cited by this paper
• Significant Correlations between Tissue Factor and Thrombin Markers in Trauma and Septic Patients with Disseminated Intravascular Coagulation

  1998cited by this paper
• Comparison of plasma tissue factor levels in unstable and stable angina pectoris.

  1998cited by this paper
• The Role of the Tissue Factor Pathway in the Hypercoagulable State in Patients with the Antiphospholipid Syndrome

  1998cited by this paper
• Platelet microparticles and calcium homeostasis in acute coronary ischemias

  1997cited by this paper
• Increased plasma tissue factor levels in acute myocardial infarction.

  1997cited by this paper
• Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant.

  1997influential reference
• Mechanism of tissue factor activation on HL-60 cells.

  1997cited by this paper
• Factor XI Activation by Meizothrombin: Stimulation by Phospholipid Vesicles Containing both Phosphatidylserine and Phosphatidylethanolamine

  1997cited by this paper
• Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation

  1996cited by this paper
• Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation

  1996cited by this paper
• Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor- dependent coagulation pathway

  1996cited by this paper
• Association of smooth muscle cell tissue factor with caveolae.

  1996cited by this paper
• Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia.

  1994cited by this paper
• Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias.

  1993cited by this paper
• Expression of tissue factor procoagulant activity: regulation by cytosolic calcium.

  1990cited by this paper
• Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans.

  1989cited by this paper
• Tissue factor and hemostasis.

  1988cited by this paper
• Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery.

  1986cited by this paper
• Factor Va-factor Xa interaction. Effects of phospholipid vesicles of varying composition.

  1982cited by this paper
• Single bilayer vesicles prepared without sonication. Physico-chemical properties.

  1976cited by this paper
• THE THROMBOPLASTIN REAGENT FOR THE DETERMINATION OF PROTHROMBIN.

  1940cited by this paper

• Hypoxia stimulates blood-brain barrier disruption and systemic appearance of pro-coagulant, brain-derived extracellular vesicles: Implications in transient ischaemic attack patients.

  2026cites this paper
• Research and prospects of strategies for surface-modified coatings on blood-contacting materials

  2025influential citation
• PREDICT-EV, Identifying Novel Biomarkers to Predict Stroke Risk: A Nested, Case-controlled Clinical Trial Protocol

  2025cites this paper
• Development and evaluation of an electrical impedance tomography (EIT) sensor for real-time monitoring of hemolysis dynamics.

  2025cites this paper
• Extracellular vesicles from the lung pro-thrombotic niche drive cancer-associated thrombosis and metastasis via integrin beta 2.

  2025cites this paper
• Extracellular vesicles in atherosclerosis cardiovascular disease: emerging roles and mechanisms

  2025cites this paper
• The new composition of circulating microvesicles: optimized protocols and reassessment of their characteristics and physiological functions

  2025cites this paper
• Prothrombotic Microvesicle Generation in Pediatric Cardiopulmonary Bypass: A Pilot Observational Study

  2025cites this paper
• Extracellular vesicles in ageing cold‐stored whole blood may not compensate for the decreasing haemostatic function in vitro

  2025cites this paper
• Malondialdehyde-specific natural IgM inhibit NETosis triggered by culprit site–derived extracellular vesicles from myocardial infarction patients

  2024cites this paper
• Role of Exosomes in Cardiovascular Diseases

  2024cites this paper
• Differential effects of physiological agonists on the proteome of platelet‐derived extracellular vesicles

  2024cites this paper
• Pathogenic Mechanisms, Diagnostic, and Therapeutic Potential of Microvesicles in Diabetes and Its Complications.

  2024cites this paper
• Microvesicle Tissue Factor Procoagulant Activity Is Elevated and Correlated With Disease Severity in Patients With Cirrhosis

  2024cites this paper
• Research into New Molecular Mechanisms in Thrombotic Diseases Paves the Way for Innovative Therapeutic Approaches

  2024cites this paper
• Circulating Microparticles: Optimization and Standardization of Isolation Protocols and Reassessment of Their Characteristics and Functions

  2023cites this paper
• Extracellular Vesicles in Cancer Drug Resistance: Implications on Melanoma Therapy

  2023cites this paper
• Adhesive properties of plasma-circulating and platelet-derived microvesicles from healthy individuals.

  2023cites this paper
• Effect of Mesenchymal Stem Cell Derived Ex-osomes on the Healing Process of Chronic Diabetic Wound

  2023cites this paper
• Shear stimulated red blood cell microparticles: Effect on clot structure, flow and fibrinolysis

  2023cites this paper
• Extracellular Vesicles in Pulmonary Hypertension: A Dangerous Liaison?

  2023cites this paper
• Mesenchymal stem cell-derived exosomes: The dawn of diabetic wound healing

  2022cites this paper
• Effect of Extracellular Vesicles From Multiple Cells on Vascular Smooth Muscle Cells in Atherosclerosis

  2022cites this paper
• Neutrophil Extracellular Traps and Neutrophil-Derived Extracellular Vesicles: Common Players in Neutrophil Effector Functions

  2022cites this paper
• Extracellular vesicles in atherothrombosis: From biomarkers and precision medicine to therapeutic targets

  2022cites this paper
• Dysregulation of Biomarkers of Hemostatic Activation and Inflammatory Processes are Associated with Adverse Outcomes in Pulmonary Embolism

  2022cites this paper
• Blood Cell-Derived Microvesicles in Hematological Diseases and beyond

  2022cites this paper
• Transfusion policy in pediatric extracorporeal membrane oxygenation patients: Less could be more

  2022cites this paper
• Extracellular Vesicles as Drivers of Immunoinflammation in Atherothrombosis

  2022cites this paper
• Protocol for Measuring Concentrations of Extracellular Vesicles in Human Blood Plasma with Flow Cytometry.

  2022cites this paper
• Pioneer Role of Extracellular Vesicles as Modulators of Cancer Initiation in Progression, Drug Therapy, and Vaccine Prospects

  2022cites this paper
• On neutrophil extracellular traps in leukocyte-dependent inflammation

  2022cites this paper
• Extracellular Vesicles and Their Use as Vehicles of Immunogens.

  2022cites this paper
• Neurovascular Unit-Derived Extracellular Vesicles: From Their Physiopathological Roles to Their Clinical Applications in Acute Brain Injuries

  2022cites this paper
• Early but reversible haemostatic changes in a-symptomatic females expressing COVID-19 antibodies

  2022cites this paper
• Pathophysiology of Coagulation and Emerging Roles for Extracellular Vesicles in Coagulation Cascades and Disorders

  2022cites this paper
• Effect of washing units of canine red blood cells on storage lesions

  2021cites this paper
• Role of Circulating Microparticles in Type 2 Diabetes Mellitus: Implications for Pathological Clotting

  2021cites this paper
• Thermosensitive and tum or microenvironment activated nanotheranostics for the chemodynamic/photothermal therapy of colorectal tumor.

  2021cites this paper
• Exosomes: Emerging Cell-Free Based Therapeutics in Dermatologic Diseases

  2021cites this paper
• Increased circulating erythrocyte-derived microparticles in patients with acute coronary syndromes.

  2021cites this paper
• Extracellular vesicles and female reproduction

  2021cites this paper
• High-Efficient Vacuum Ultraviolet-Ozone Assist-Deposited Polydopamine for Poly(lactic-co-glycolic acid)-Coated Pure Zn toward Biodegradable Cardiovascular Stent Applications.

  2021cites this paper
• Extracellular vesicles in renal inflammatory and infectious diseases.

  2021cites this paper
• Extracellular Vesicles: Novel Opportunities to Understand and Detect Neoplastic Diseases

  2021cites this paper
• Using single-vesicle technologies to unravel the heterogeneity of extracellular vesicles

  2021cites this paper
• Phosphatidylserine Exposing Extracellular Vesicles in Pre-eclamptic Patients

  2021cites this paper
• Extracellular Vesicles and Thrombosis: Update on the Clinical and Experimental Evidence

  2021influential citation
• Production of erythrocyte microparticles in a sub-hemolytic environment

  2021cites this paper
• Endothelial Extracellular Vesicles: From Keepers of Health to Messengers of Disease

  2021cites this paper
• Extracellular Vesicles: A Double-Edged Sword in Sepsis

  2021cites this paper
• Platelet-Leukocyte Interplay in Cancer Development and Progression

  2020cites this paper
• Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19)

  2020cites this paper
• Effect of blood flow on platelets, leukocytes, and extracellular vesicles in thrombosis of simulated neonatal extracorporeal circulation

  2020cites this paper
• Platelet-leukocyte interplay during vascular disease.

  2020cites this paper
• Endothelial Cell-Derived Microparticle

  2020cites this paper
• Improved biocompatibility and degradation behavior of biodegradable Zn-1Mg by grafting zwitterionic phosphorylcholine chitosan (PCCs) coating on silane pre-modified surface

  2020cites this paper
• Extracellular Vesicles Derived from Plasmodium-infected and Non-infected Red Blood Cells as Targeted Drug Delivery Vehicles.

  2020cites this paper
• Pursuing mechanisms of extracellular vesicle formation. Effects of sample processing

  2020cites this paper
• A new hybrid immunocapture bioassay with improved reproducibility to measure tissue factor-dependent procoagulant activity of microvesicles from body fluids.

  2020cites this paper
• Tissue Engineered Vascular Graft Recipient Interleukin 10 Status Is Critical for Preventing Thrombosis

  2020cites this paper
• Platelets and Metastasis: New Implications of an Old Interplay

  2020cites this paper
• Shedding Light on the Role of Extracellular Vesicles in HIV Infection and Wound Healing

  2020cites this paper
• High levels of endothelial and platelet microvesicles in patients with type 1 diabetes irrespective of microvascular complications.

  2020cites this paper
• The Role of Extracellular Vesicles as Allies of HIV, HCV and SARS Viruses

  2020cites this paper
• Assessment of extracellular vesicles using IFC for application in transfusion medicine.

  2020cites this paper
• Erythrocytes as model cells for biocompatibility assessment, cytotoxicity screening of xenobiotics and drug delivery.

  2020cites this paper
• Extracellular Vesicles as Potential Prognostic Markers of Lymphatic Dysfunction

  2020cites this paper
• Synthesis and compatibility evaluation of versatile mesoporous silica nanoparticles with red blood cells: an overview

  2019cites this paper
• Current Insights on the Etiology and Pathogenesis of Venous Thrombosis: Virchow's Triad Revision

  2019cites this paper
• Characterization and function of medium and large extracellular vesicles from plasma and urine by surface antigens and Annexin V

  2019cites this paper
• Increasing the sensitivity of the human microvesicle tissue factor activity assay.

  2019cites this paper
• Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis

  2019cites this paper
• Clearance and phenotype of extracellular vesicles after red blood cell transfusion in a human endotoxemia model.

  2019cites this paper
• Thrombosis Risk in Cancer Patients Receiving Red Blood Cell Transfusions

  2019cites this paper
• Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

  2019cites this paper
• Microvesicles and Cancer Associated Thrombosis

  2019cites this paper
• Tissue Factor-Negative Cell-Derived Microparticles Play a Distinctive Role in Hemostasis: A Viewpoint Review

  2019cites this paper
• Transfusion of autologous extracellular vesicles from stored red blood cells does not affect coagulation in a model of human endotoxemia

  2018cites this paper
• The exosomes released from different cell types and their effects in wound healing

  2018cites this paper
• Proceedings of the Food and Drug Administration's public workshop on new red blood cell product regulatory science 2016

  2018cites this paper
• Human bone marrow contains high levels of extracellular vesicles with a tissue-specific subtype distribution

  2018cites this paper
• RBC Transfusion Practice in Pediatric Extracorporeal Membrane Oxygenation Support

  2018cites this paper
• Assessment of the Procoagulant Activity of Microparticles and the Protein Z System in Patients Undergoing Off-Pump Coronary Artery Bypass Surgery

  2018cites this paper
• Diagnostic value of platelet-derived microparticles in pulmonary thromboembolism: A population-based study.

  2018cites this paper
• Circulating Microparticles and Coagulation Profiles in Patients with Advanced Stage Solid Tumors

  2018cites this paper
• Microparticles and Exercise in Clinical Populations.

  2018cites this paper
• Blood-Contacting Biomaterials: In Vitro Evaluation of the Hemocompatibility

  2018cites this paper
• Tryptophan-Derived Uremic Toxins and Thrombosis in Chronic Kidney Disease

  2018cites this paper
• Standardization of a fast and effective method for the generation and detection of platelet-derived microparticles by a flow cytometer.

  2018cites this paper
• Physiologic Impact of Circulating RBC Microparticles upon Blood-Vascular Interactions

  2018cites this paper
• Extracellular vesicles: pathogenetic, diagnostic and therapeutic value in traumatic brain injury

  2018cites this paper
• Squeezing for Life – Properties of Red Blood Cell Deformability

  2018cites this paper
• Extracellular vesicles from human saliva promote hemostasis by delivering coagulant tissue factor to activated platelets

  2018cites this paper
• Brain-Derived Microparticles in Patients with Severe Isolated TBI

  2017cites this paper
• Observational retrospective study of vascular modulator changes during treatment in essential thrombocythemia

  2017cites this paper
• Tumor-Derived Exosomes Induce the Formation of Neutrophil Extracellular Traps: Implications For The Establishment of Cancer-Associated Thrombosis

  2017cites this paper
• Influence of red blood cell-derived microparticles upon vasoregulation.

  2017cites this paper
• Applicability of extracellular vesicles in clinical studies

  2017cites this paper
• Endothelial- and Immune Cell-Derived Extracellular Vesicles in the Regulation of Cardiovascular Health and Disease

  2017cites this paper